More than 90% of mirikizumab-mrkz-treated patients who were in clinical remission at one year…
Tag:
Mirikizumab-mrkz
-
-
Lifestyle & Healthslider
FDA approves Mirikizumab-mrkz for Crohn’s disease, expanding its use to the second major type of inflammatory bowel disease
by Karine Ayoubby Karine AyoubIn the pivotal Phase 3 VIVID-1 trial, patients treated with Mirikizumab-mrkz experienced significant improvement…